Index of medicine substances

Eptifibatide  •  Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin (B01AC16)

Eptinezumab  •  Nervous system | Antimigraine preparations | Calcitonin gene-related peptide (CGRP) antagonists (N02CD05)

Eptotermin alfa  •  Musculo-skeletal system | Drugs affecting bone structure and mineralization | Bone morphogenetic proteins (M05BC02)

Equine rabies immunoglobulin  •  Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins (J06BB05)

Eravacycline  •  Antiinfectives for systemic use | Tetracyclines (J01AA13)

Erdafitinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors (L01EX16)

Erdosteine  •  Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics (R05CB15)

Erenumab  •  Nervous system | Antimigraine preparations | Calcitonin gene-related peptide (CGRP) antagonists (N02CD01)

Ergocalciferol  •  Alimentary tract and metabolism | Vitamin A and D, including combinations of the two | Vitamin D and analogues (A11CC01)

Ergometrine  •  Genito urinary system and sex hormones | Uterotonics | Ergot alkaloids (G02AB03)

Eribulin  •  Antineoplastic and immunomodulating agents | Other antineoplastic agents (L01XX41)

Erlotinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (L01EB02)

Ertapenem  •  Antiinfectives for systemic use | Other beta-lactam antibacterials | Carbapenems (J01DH03)

Ertugliflozin  •  Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sodium-glucose co-transporter 2 (SGLT2) inhibitors (A10BK04)

Ertugliflozin + metformin  •  Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Combinations of oral blood glucose lowering drugs (A10BD23)

Ertugliflozin + sitagliptin  •  Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Combinations of oral blood glucose lowering drugs (A10BD24)

Erythromycin  •  Antiinfectives for systemic use | Macrolides, lincosamides and streptogramins (J01FA01)

Erythromycin + tretinoin  •  Dermatologicals | Anti-acne preparations | Anti-acne preparations for topical use | Antiinfectives for treatment of acne (D10AF52)

Erythromycin + zinc acetate  •  Dermatologicals | Anti-acne preparations | Anti-acne preparations for topical use | Antiinfectives for treatment of acne (D10AF52)

Escin  •  Cardiovascular system | Capillary stabilizing agents | Other capillary stabilizing agents (C05CXN1)

Escin + diethylamine salicylate  •  Cardiovascular system | Capillary stabilizing agents | Other capillary stabilizing agents (C05CXN1)

Escitalopram  •  Nervous system | Antidepressants | Selective serotonin reuptake inhibitors (N06AB10)

Esketamine  •  Nervous system | Antidepressants | Other antidepressants (N06AX27)

Eslicarbazepine  •  Nervous system | Antiepileptics | Antiepileptics | Carboxamide derivatives (N03AF04)

Esmolol  •  Cardiovascular system | Beta blocking agents | Beta blocking agents | Beta blocking agents, selective (C07AB09)

Esomeprazole  •  Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Proton pump inhibitors (A02BC05)

Essential phospholipids  •  Alimentary tract and metabolism | Liver therapy, lipotropics (A05BA10)

Estradiol  •  Genito urinary system and sex hormones | Estrogens | Natural and semisynthetic estrogens, plain (G03CA03)

Estradiol valerate + dienogest  •  Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens and estrogens, sequential preparations (G03AB08)

Estradiol + cyproterone  •  Genito urinary system and sex hormones | Antiandrogens | Antiandrogens and estrogens (G03HB01)